XML 27 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:      
Research and Development Expense $ 69,637 $ 89,423 $ 68,032
General and administrative 71,809 16,534 11,988
Total operating expenses 141,446 105,957 80,020
Operating loss (141,446) (105,957) (80,020)
Interest income 8,510 7,833 2,777
Other income, net 411 907 997
gain from change in fair value of warrant liabilities, liability 108,183 0 0
Net loss $ (24,342) $ (97,217) $ (76,246)
Shares used in computing net loss per share, basic (in shares) 46,329 41,932 40,202
Net loss per share, basic (in dollars per share) $ (0.53) $ (2.32) $ (1.9)
Net loss $ (24,342) $ (97,217) $ (76,246)
Adjustment for change in fair value of warrant liabilities (43,793) 0 0
Adjusted numerator, diluted $ (68,135) $ (97,217) $ (76,246)
Shares used in computing net loss per share, diluted (in shares) 46,604 41,932 40,202
Net loss per share, diluted (in dollars per share) $ (1.46) $ (2.32) $ (1.9)